Business Context and Reporting Period
This Form 8-K is a current report filed by Astrotech Corp on August 8, 2016. The filing addresses a material modification to the rights of securities holders regarding the company's poison pill defense mechanism (Rights Agreement).
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a corporate governance report focused on the terms of a shareholder rights plan.
Material Changes
On August 4, 2016, the Company and the Rights Agent entered into Amendment Seven to the Rights Agreement. The material changes include:
- Expiration Date Extension: The expiration date of the Rights was extended from August 10, 2016, to August 10, 2017.
- Purchase Price Reduction: The Purchase Price for each one one-thousandth of a share of the Company's Series D Junior Participating Preferred Stock was decreased from $3.06 to $2.29.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of operational risks. The primary purpose is to disclose the amendment to the Rights Agreement, which serves as a defensive measure against potential hostile takeovers. The filing references the full text of Amendment Seven as Exhibit 4.1 for complete legal terms.
Investor Verification Checklist
- Verify the new expiration date of the Rights Agreement (August 10, 2017).
- Confirm the adjusted purchase price of $2.29 for the Series D Junior Participating Preferred Stock.
- Review the full text of Amendment Seven (Exhibit 4.1) for any other modified terms not summarized in the 8-K.
- Check subsequent filings to determine if the Rights are redeemed, exchanged, or further amended before the new expiration date.